0001209191-22-006492.txt : 20220202 0001209191-22-006492.hdr.sgml : 20220202 20220202173838 ACCESSION NUMBER: 0001209191-22-006492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gros David-Alexandre C CENTRAL INDEX KEY: 0001644489 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 22585057 MAIL ADDRESS: STREET 1: 220 MARLBOROUGH STREET STREET 2: #6 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-238-8090 MAIL ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Novus Therapeutics, Inc. DATE OF NAME CHANGE: 20170511 FORMER COMPANY: FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc DATE OF NAME CHANGE: 20070622 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-01 0 0001404281 Eledon Pharmaceuticals, Inc. ELDN 0001644489 Gros David-Alexandre C C/O ELEDON PHARMACEUTICALS, INC. 19900 MACARTHUR BLVD STE. 550 IRVINE CA 92612 1 1 0 0 Chief Executive Officer Stock Option (right to buy) 3.97 2022-02-01 4 A 0 108000 0.00 A 2032-02-01 Common Stock 108000 108000 D This option represents a right to purchase up to 108,000 shares of Common Stock, which option vests with respect to 27,000 shares on February 1, 2023, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending February 1, 2026. /s/ David-Alexandre C. Gros 2022-02-02